GO:0047757 chondroitin-glucuronate 5-epimerase activity

Chondroitin-glucuronate 5-epimerase activity (GO:0047757) is a molecular function that catalyzes the conversion of D-glucuronate to L-iduronate residues within chondroitin/dermatan sulfate glycosaminoglycan chains. This epimerization reaction is a critical step in the biosynthesis of dermatan sulfate, a sulfated glycosaminoglycan that participates in extracellular matrix assembly, cell signaling, and tissue development. The enzyme responsible for this activity, dermatan sulfate epimerase (DSE), was identified as identical to SART2, a tumor-associated antigen, linking this enzymatic activity to cancer biology. Researchers study GO:0047757 to understand how glycosaminoglycan fine structure is regulated and how perturbations contribute to disease. The activity is not merely a housekeeping function; it determines the ratio of glucuronic acid to iduronic acid in chondroitin/dermatan sulfate, which in turn affects binding to growth factors, cytokines, and extracellular matrix proteins. TGF-beta1 has been shown to regulate the expression of polymer-modifying enzymes, including chondroitin-glucuronate 5-epimerase, thereby altering the fine structure of chondroitin/dermatan sulfate. Given its role in matrix biology and cancer, GO:0047757 is a target for functional genomics. CRISPR-based models allow researchers to knock out DSE, introduce point mutations in its catalytic domain, or knock in tags to track its localization and interactions. This article provides a comprehensive overview of the term, its mechanism, associated genes, disease relevance, and experimental approaches.

GO:0047757 chondroitin-glucuronate 5-epimerase activity is defined as the catalysis of the reaction: chondroitin D-glucuronate = dermatan L-iduronate. In other words, it is the enzyme activity that epimerizes the C5 position of D-glucuronic acid residues in chondroitin sulfate chains, converting them to L-iduronic acid residues, which is a hallmark of dermatan sulfate biosynthesis.

GO:0047757 is important because it governs the structural diversity of chondroitin/dermatan sulfate, a major class of glycosaminoglycans that modulate cell adhesion, migration, proliferation, and differentiation. The epimerization of D-glucuronate to L-iduronate is a rate-limiting step that determines the iduronic acid content of dermatan sulfate, which directly influences the binding of growth factors such as TGF-beta1 and fibroblast growth factors. Dysregulation of this activity has been linked to cancer progression, fibrosis, and developmental abnormalities. Understanding the molecular function of chondroitin-glucuronate 5-epimerase is therefore essential for both basic matrix biology and translational research.

The following genes and proteins are directly or indirectly involved in chondroitin-glucuronate 5-epimerase activity and dermatan sulfate biosynthesis.

Chondroitin-glucuronate 5-epimerase activity is regulated at multiple levels. Transcriptionally, TGF-beta1 signaling upregulates the expression of DSE and other polymer-modifying enzymes, leading to increased iduronic acid content in chondroitin/dermatan sulfate. Post-translationally, the enzyme may be subject to glycosylation and proteolytic processing, although specific modifications remain to be fully characterized. Additionally, the availability of substrate (chondroitin sulfate chains) and the presence of sulfotransferases that act on iduronic acid residues can influence the net epimerization rate.

DSE (SART2) was originally identified as a tumor-associated antigen, and its expression is altered in various cancers. The epimerase activity of DSE contributes to the synthesis of dermatan sulfate, which can promote tumor cell proliferation, migration, and invasion by modulating growth factor signaling and extracellular matrix remodeling. Targeting DSE activity may therefore represent a therapeutic strategy in cancers with aberrant dermatan sulfate biosynthesis.

TGF-beta1 is a master regulator of fibrosis, and its ability to upregulate chondroitin-glucuronate 5-epimerase suggests a role for this enzyme in fibrotic diseases. Increased dermatan sulfate synthesis and altered fine structure may contribute to tissue stiffening and scarring. Inhibiting DSE activity could potentially attenuate fibrotic progression.

Defects in glycosaminoglycan biosynthesis, including dermatan sulfate, are associated with connective tissue disorders such as Ehlers-Danlos syndrome and spondyloepimetaphyseal dysplasia. Although mutations in DSE itself are not classically linked to these disorders, the enzyme's role in matrix assembly implies that its dysfunction could contribute to similar phenotypes.

To measure chondroitin-glucuronate 5-epimerase activity, researchers digest chondroitin/dermatan sulfate chains with chondroitinases and analyze the resulting disaccharides by HPLC or mass spectrometry. The ratio of iduronic acid-containing disaccharides to glucuronic acid-containing disaccharides reflects epimerase activity.

Recombinant DSE can be incubated with chondroitin sulfate substrates, and the formation of iduronic acid can be monitored using specific antibodies or chromatography. This method allows kinetic characterization of the enzyme and testing of inhibitors.

CRISPR-Cas9 knockout of DSE in cell lines followed by glycosaminoglycan analysis, RNA-seq, and proteomics can reveal downstream effects on matrix composition and cell behavior. This approach is powerful for identifying compensatory pathways and disease-relevant phenotypes.

DSE mRNA and protein levels can be quantified using qPCR and Western blotting, respectively. These methods are used to study regulation by TGF-beta1 and other factors.

Researchers studying chondroitin-glucuronate 5-epimerase activity-related genes often need to determine whether a candidate gene is causally involved in dermatan sulfate biosynthesis, matrix remodeling, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of DSE and related pathway genes.

Chondroitin-glucuronate 5-epimerase activity (GO:0047757) is a critical enzymatic function in the biosynthesis of dermatan sulfate, influencing extracellular matrix structure and cell signaling. The enzyme DSE (SART2) catalyzes this epimerization and is regulated by TGF-beta1, with implications in cancer and fibrosis. Understanding this activity through CRISPR-based models and biochemical assays will advance both basic glycosaminoglycan biology and translational medicine.